190 related articles for article (PubMed ID: 28104681)
1. Copy number variations of
Rocca MS; Di Nisio A; Marchiori A; Ghezzi M; Opocher G; Foresta C; Ferlin A
Endocr Relat Cancer; 2017 Mar; 24(3):119-125. PubMed ID: 28104681
[TBL] [Abstract][Full Text] [Related]
2. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in AKT1, PTEN and the 8q24 locus, and the risk of testicular germ cell tumor.
Andreassen KE; Kristiansen W; Karlsson R; Aschim EL; Dahl O; Fosså SD; Adami HO; Wiklund F; Haugen TB; Grotmol T
Hum Reprod; 2013 Jul; 28(7):1995-2002. PubMed ID: 23639623
[TBL] [Abstract][Full Text] [Related]
4. E2F1 germline copy number variations and melanoma susceptibility.
Rocca MS; Benna C; Mocellin S; Rossi CR; Msaki A; Di Nisio A; Opocher G; Foresta C
J Transl Med; 2019 May; 17(1):181. PubMed ID: 31142321
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of SPRY4 and SPRY4-IT1 inhibits cell growth and phosphorylation of Akt in human testicular germ cell tumours.
Das MK; Furu K; Evensen HF; Haugen ØP; Haugen TB
Sci Rep; 2018 Feb; 8(1):2462. PubMed ID: 29410498
[TBL] [Abstract][Full Text] [Related]
6. E2F1 copy number variations in germline and breast cancer: a retrospective study of 222 Italian women.
Rocca MS; Benna C; Goldin E; Di Nisio A; De Toni L; Cosci I; Marchet A; Nitti D; Foresta C
Mol Med; 2021 Mar; 27(1):26. PubMed ID: 33691613
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylation-driven AKT Serine/Threonine Kinase 3 promotes testicular germ cell tumors proliferation and negatively correlates to immune infiltration.
Luo Y; Zhou Q; Zhu F; Fan L; Bo H; Wang X
Bioengineered; 2021 Dec; 12(2):11288-11302. PubMed ID: 34882061
[TBL] [Abstract][Full Text] [Related]
8. Analysis of single nucleotide polymorphisms of FSH receptor gene suggests association with testicular cancer susceptibility.
Ferlin A; Pengo M; Selice R; Salmaso L; Garolla A; Foresta C
Endocr Relat Cancer; 2008 Jun; 15(2):429-37. PubMed ID: 18430895
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
[TBL] [Abstract][Full Text] [Related]
10. Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population.
Kristiansen W; Andreassen KE; Karlsson R; Aschim EL; Bremnes RM; Dahl O; Fosså SD; Klepp O; Langberg CW; Solberg A; Tretli S; Adami HO; Wiklund F; Grotmol T; Haugen TB
Hum Reprod; 2012 May; 27(5):1525-35. PubMed ID: 22402210
[TBL] [Abstract][Full Text] [Related]
11. Genetic changes associated with testicular cancer susceptibility.
Pyle LC; Nathanson KL
Semin Oncol; 2016 Oct; 43(5):575-581. PubMed ID: 27899190
[TBL] [Abstract][Full Text] [Related]
12. The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors.
Juliachs M; Muñoz C; Moutinho CA; Vidal A; Condom E; Esteller M; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F
Clin Cancer Res; 2014 Feb; 20(3):658-67. PubMed ID: 24277456
[TBL] [Abstract][Full Text] [Related]
13. Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.
Boublikova L; Bakardjieva-Mihaylova V; Skvarova Kramarzova K; Kuzilkova D; Dobiasova A; Fiser K; Stuchly J; Kotrova M; Buchler T; Dusek P; Grega M; Rosova B; Vernerova Z; Klezl P; Pesl M; Zachoval R; Krolupper M; Kubecova M; Stahalova V; Abrahamova J; Babjuk M; Kodet R; Trka J
Cancer Lett; 2016 Jul; 376(2):367-76. PubMed ID: 27085458
[TBL] [Abstract][Full Text] [Related]
14. Protein overexpression and gene amplification of epidermal growth factor receptor in adult testicular germ cell tumors: potential role in tumor progression.
Miyai K; Yamamoto S; Asano T; Tamai S; Matsubara O; Tsuda H
Cancer Sci; 2010 Sep; 101(9):1970-6. PubMed ID: 20608935
[TBL] [Abstract][Full Text] [Related]
15. Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition Gene.
Litchfield K; Loveday C; Levy M; Dudakia D; Rapley E; Nsengimana J; Bishop DT; Reid A; Huddart R; Broderick P; Houlston RS; Turnbull C
Eur Urol; 2018 Jun; 73(6):828-831. PubMed ID: 29433971
[TBL] [Abstract][Full Text] [Related]
16. Genomic screening of testicular germ cell tumors from monozygotic twins.
Silveira SM; da Cunha IW; Marchi FA; Busso AF; Lopes A; Rogatto SR
Orphanet J Rare Dis; 2014 Nov; 9():181. PubMed ID: 25424124
[TBL] [Abstract][Full Text] [Related]
17. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
[TBL] [Abstract][Full Text] [Related]
18. Common variants identified in genome-wide association studies of testicular germ cell tumour: an update, biological insights and clinical application.
Litchfield K; Shipley J; Turnbull C
Andrology; 2015 Jan; 3(1):34-46. PubMed ID: 25598472
[TBL] [Abstract][Full Text] [Related]
19. Expression of splicing variants of the inhibitor of apoptosis livin in testicular germ cell tumors.
Kempkensteffen C; Hinz S; Krause H; Jager T; Köllermann J; Weikert S; Christoph F; Schostak M; Miller K; Schrader M
Tumour Biol; 2008; 29(2):76-82. PubMed ID: 18515985
[TBL] [Abstract][Full Text] [Related]
20. IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
Selfe J; Goddard NC; McIntyre A; Taylor KR; Renshaw J; Popov SD; Thway K; Summersgill B; Huddart RA; Gilbert DC; Shipley JM
J Pathol; 2018 Feb; 244(2):242-253. PubMed ID: 29160922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
